Development and validation of a novel lysosome-related LncRNA signature for predicting prognosis and the immune landscape features in colon cancer
Abstract Lysosomes are essential components for managing tumor microenvironment and regulating tumor growth. Moreover, recent studies have also demonstrated that long non-coding RNAs could be used as a clinical biomarker for diagnosis and treatment of colorectal cancer. However, the influence of lys...
Main Authors: | Fengming Li, Wenyi Wang, Guanbiao Lai, Shiqian Lan, Liyan Lv, Shengjie Wang, Xinli Liu, Juqin Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-51126-9 |
Similar Items
-
A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
by: Xiaorui Fu, et al.
Published: (2020-04-01) -
Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
by: Pan Chen, et al.
Published: (2023-11-01) -
A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
by: Jian Luo, et al.
Published: (2022-08-01) -
A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
by: Dongming Li, et al.
Published: (2023-04-01) -
Identification of a Genome Instability-Associated LncRNA Signature for Prognosis Prediction in Colon Cancer
by: Tengfei Yin, et al.
Published: (2021-06-01)